Osaic Holdings’s Monogram Orthopaedics MGRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,350
Closed -$7.89K 8033
2025
Q3
$7.89K Sell
1,350
-85
-6% -$454 ﹤0.01% 6507
2025
Q2
$4.14K Buy
1,435
+585
+69% +$1.58K ﹤0.01% 6640
2025
Q1
$2.5K Sell
850
-500
-37% -$1.32K ﹤0.01% 6509
2024
Q4
$3.2K Buy
1,350
+352
+35% +$825 ﹤0.01% 6414
2024
Q3
$2.64K Buy
998
+130
+15% +$339 ﹤0.01% 6494
2024
Q2
$1.87K Sell
868
-2,882
-77% -$6.32K ﹤0.01% 6622
2024
Q1
$9.15K Buy
3,750
+1,200
+47% +$3.54K ﹤0.01% 5795
2023
Q4
$8.77K Buy
2,550
+300
+13% +$904 ﹤0.01% 5904
2023
Q3
$5.85K Buy
2,250
+2,182
+3,209% +$9.18K ﹤0.01% 6202
2023
Q2
$267 Buy
+68
New +$352 ﹤0.01% 7161

Osaic Holdings's MGRM Position: Q4 2025 in Review

Osaic Holdings sold out of Monogram Orthopaedics (MGRM) in Q4 2025, closing a stake of 1,350 shares — an estimated $7.89K sold.

Osaic Holdings first reported a position in MGRM in Q2 2023 and held it in 10 quarters. The position peaked at $9.15K in Q1 2024. 0 funds tracked by Wall St. Rank hold MGRM as of Q4 2025.

  • Osaic Holdings reported no remaining Monogram Orthopaedics position as of Q4 2025 after selling out during the quarter.
  • Osaic Holdings sold 1,350 Monogram Orthopaedics shares in Q4 2025, an estimated $7.89K.
  • Osaic Holdings first reported a position in Monogram Orthopaedics in Q2 2023 and held it in 10 quarters.
  • Osaic Holdings's Monogram Orthopaedics position peaked at $9.15K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q4 2025.

Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.